The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...

Venus Remedies is collaborating with UK-based Infex Therapeutics for the clinical development of MET-X, a ...

Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat ...

India has developed a novel antibiotic to fight antimicrobial resistance (AMR), as well as a new drug to tackle burden of ...

Through this platform, resistance in bacterial samples can be tested within two hours compared to 24-27 hours through other ...

The global penicillin drug market size was valued at US$ 8.71 billion in 2023 and is projected to reach US$ 12.08 billion by 2032, registering a CAGR of 3.7% during the forecast period from 2024 to ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 14:45 Hrs [IST] ...

CrisprBits' latest study, published in Nature Scientific Reports, showcases PathCrisp’s ability to detect carbapenem ...

Antimicrobial resistance (AMR) is a critical global health challenge, requiring early and accurate detection of resistance ...

Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to ...